# InvenTrust Properties Corp.: financial statements, quarterly

IVT · NYSE · CIK 1307748 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ivt.md) · [Financials](/companies/ivt/financials.md) · [Filings](/companies/ivt/filings.md) · [Insiders](/companies/ivt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ivt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [64.7 d](/filings/0001307748-26-000045.md) | [0.3](/filings/0001307748-25-000085.md) | [0.4](/filings/0001307748-25-000157.md) | [0.4](/filings/0001307748-25-000185.md) | [273 d](/filings/0001307748-26-000045.md) | [0.4](/filings/0001307748-26-000112.md) | [0.4](/filings/0001307748-26-000194.md) | [0.4](/filings/0001307748-26-000213.md) | [298 d](/filings/0001307748-26-000045.md) | [0.5](/filings/0001307748-26-000112.md) | [0.5](/filings/0001307748-26-000194.md) | [0.5](/filings/0001307748-26-000213.md) |
| Operating income | $m | [(6.1) d](/filings/0001307748-26-000045.md) | [(8.8)](/filings/0001307748-25-000085.md) | [(9.2)](/filings/0001307748-25-000157.md) | [(12.8)](/filings/0001307748-25-000185.md) | [(2.6) d](/filings/0001307748-26-000045.md) | [(7.7)](/filings/0001307748-26-000112.md) | [83.5](/filings/0001307748-26-000194.md) | [(7.3)](/filings/0001307748-26-000213.md) | [(8.5) d](/filings/0001307748-26-000045.md) | [(9.8)](/filings/0001307748-26-000112.md) | [(11.3)](/filings/0001307748-26-000194.md) | [4.2](/filings/0001307748-26-000213.md) |
| Interest expense | $m | [9.7 d](/filings/0001307748-24-000016.md) | [9.6](/filings/0001307748-24-000045.md) | [9.6](/filings/0001307748-25-000157.md) | [9.5](/filings/0001307748-25-000185.md) | [8.4 d](/filings/0001307748-26-000045.md) | [8.3](/filings/0001307748-26-000112.md) | [8.3](/filings/0001307748-26-000194.md) | [9.0](/filings/0001307748-26-000213.md) | [8.9 d](/filings/0001307748-26-000045.md) | [10.1](/filings/0001307748-26-000112.md) | [11.3](/filings/0001307748-26-000194.md) | [13.2](/filings/0001307748-26-000213.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [2.9 d](/filings/0001307748-26-000045.md) | [2.9](/filings/0001307748-25-000185.md) | [1.5](/filings/0001307748-25-000185.md) | [(0.5)](/filings/0001307748-25-000185.md) | [9.8 d](/filings/0001307748-26-000045.md) | [6.8](/filings/0001307748-26-000213.md) | [95.9](/filings/0001307748-26-000213.md) | [6.0](/filings/0001307748-26-000213.md) | [2.7 d](/filings/0001307748-26-000045.md) | [5.2](/filings/0001307748-26-000213.md) | [1.4](/filings/0001307748-26-000213.md) | [19.4](/filings/0001307748-26-000213.md) |
| Diluted EPS | $ per share | not reported | [0.04](/filings/0001307748-25-000085.md) | [0.02](/filings/0001307748-25-000157.md) | [(0.01)](/filings/0001307748-25-000185.md) | not reported | [0.09](/filings/0001307748-26-000112.md) | [1.23](/filings/0001307748-26-000194.md) | [0.08](/filings/0001307748-26-000213.md) | not reported | [0.07](/filings/0001307748-26-000112.md) | [0.02](/filings/0001307748-26-000194.md) | [0.25](/filings/0001307748-26-000213.md) |
| Basic EPS | $ per share | not reported | [0.04](/filings/0001307748-25-000085.md) | [0.02](/filings/0001307748-25-000157.md) | [(0.01)](/filings/0001307748-25-000185.md) | not reported | [0.09](/filings/0001307748-26-000112.md) | [1.24](/filings/0001307748-26-000194.md) | [0.08](/filings/0001307748-26-000213.md) | not reported | [0.07](/filings/0001307748-26-000112.md) | [0.02](/filings/0001307748-26-000194.md) | [0.25](/filings/0001307748-26-000213.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: not reported
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,487](/filings/0001307748-25-000028.md) | [2,476](/filings/0001307748-24-000045.md) | [2,460](/filings/0001307748-24-000085.md) | [2,620](/filings/0001307748-24-000101.md) | [2,636](/filings/0001307748-26-000045.md) | [2,606](/filings/0001307748-25-000085.md) | [2,709](/filings/0001307748-25-000157.md) | [2,735](/filings/0001307748-25-000185.md) | [2,789](/filings/0001307748-26-000213.md) | [2,885](/filings/0001307748-26-000112.md) | [3,034](/filings/0001307748-26-000194.md) | [3,009](/filings/0001307748-26-000213.md) |
| Total liabilities | $m | [933](/filings/0001307748-25-000028.md) | [928](/filings/0001307748-24-000045.md) | [925](/filings/0001307748-24-000085.md) | [865](/filings/0001307748-24-000101.md) | [876](/filings/0001307748-26-000045.md) | [861](/filings/0001307748-25-000085.md) | [887](/filings/0001307748-25-000157.md) | [926](/filings/0001307748-25-000185.md) | [994](/filings/0001307748-26-000213.md) | [1,107](/filings/0001307748-26-000112.md) | [1,269](/filings/0001307748-26-000194.md) | [1,230](/filings/0001307748-26-000213.md) |
| Long-term debt | $m | [815](/filings/0001307748-25-000028.md) | [828](/filings/0001307748-24-000045.md) | [812](/filings/0001307748-24-000085.md) | [740](/filings/0001307748-24-000101.md) | [740](/filings/0001307748-25-000085.md) | [741](/filings/0001307748-25-000085.md) | not reported | not reported | [823](/filings/0001307748-26-000045.md) | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,554](/filings/0001307748-26-000045.md) | [1,548](/filings/0001307748-25-000185.md) | [1,536](/filings/0001307748-25-000185.md) | [1,755](/filings/0001307748-25-000185.md) | [1,760](/filings/0001307748-26-000213.md) | [1,745](/filings/0001307748-26-000213.md) | [1,822](/filings/0001307748-26-000213.md) | [1,809](/filings/0001307748-26-000213.md) | [1,794](/filings/0001307748-26-000213.md) | [1,778](/filings/0001307748-26-000213.md) | [1,766](/filings/0001307748-26-000213.md) | [1,780](/filings/0001307748-26-000213.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [29.8 d](/filings/0001307748-26-000045.md) | [14.8](/filings/0001307748-25-000085.md) | [46.7 d](/filings/0001307748-25-000157.md) | [38.4 d](/filings/0001307748-25-000185.md) | [37.0 d](/filings/0001307748-26-000045.md) | [20.2](/filings/0001307748-26-000112.md) | [48.7 d](/filings/0001307748-26-000194.md) | [43.8 d](/filings/0001307748-26-000213.md) | [42.7 d](/filings/0001307748-26-000045.md) | [20.2](/filings/0001307748-26-000112.md) | [53.9 d](/filings/0001307748-26-000194.md) | [47.3 d](/filings/0001307748-26-000213.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [14.6 d](/filings/0001307748-26-000045.md) | [14.6](/filings/0001307748-25-000085.md) | [15.4 d](/filings/0001307748-25-000157.md) | [15.4 d](/filings/0001307748-25-000185.md) | [17.5 d](/filings/0001307748-26-000045.md) | [17.5](/filings/0001307748-26-000112.md) | [18.4 d](/filings/0001307748-26-000194.md) | [18.4 d](/filings/0001307748-26-000213.md) | [18.5 d](/filings/0001307748-26-000045.md) | [18.5](/filings/0001307748-26-000112.md) | [19.5 d](/filings/0001307748-26-000194.md) | [19.5 d](/filings/0001307748-26-000213.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.7](/filings/0001307748-24-000045.md) | [67.7](/filings/0001307748-24-000085.md) | [67.5](/filings/0001307748-24-000101.md) | [68.3](/filings/0001307748-25-000085.md) | [68.3](/filings/0001307748-25-000157.md) | [68.5](/filings/0001307748-25-000185.md) | [78.2](/filings/0001307748-26-000112.md) | [78.3](/filings/0001307748-26-000194.md) | [78.5](/filings/0001307748-26-000213.md) | [78.4](/filings/0001307748-26-000112.md) | [78.8](/filings/0001307748-26-000194.md) | [78.7](/filings/0001307748-26-000213.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 77,978,431 at 2026-10-23, from the cover of the [10-Q filed 2026-10-27](/filings/0001307748-26-000213.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 19:10 ET. No prices; not investment advice.